On Tuesday Hornbeck Offshore Services, Inc. (NYSE:HOS)’s shares enhanced 3.78%, and closed at $21.67, hitting new 52-week low high of $47.45, as the Hornbeck Offshore Services, Inc. declared that it will release its first quarter 2015 financial results after the market closes on Wednesday, April 29, 2015.
In conjunction with the release, the Corporation has planned a conference call, which will be broadcast live over the Internet, on Thursday, April 30, 2015 at 10:00 a.m. Eastern (9:00 a.m. Central).
Hornbeck Offshore Services, Inc., through its auxiliaries, operates offshore supply vessels (OSVs) and multi-purpose support vessels (MPSVs) in the U.S. Gulf of Mexico, Latin America, and internationally.
Inuvo Inc (NYSEMKT:INUV), inclined 3.66%, and closed at $2.55, hitting new 52-week high of $2.78, as On April 1, 2015, the a digital publishing and advertising technology corporation, declared its advertising contract with Yahoo! will renew under the same terms and conditions upon its anniversary on April 24, 2015.
Inuvo, Inc., together with its auxiliaries, operates as an Internet marketing and technology corporation that delivers advertisements through various networks of Websites and applications reaching desktop and mobile devices in the United States.
At the end of Tuesday’s trade, Encana Corporation (USA) (NYSE:ECA), surged 3.52%, and closed at $12.05, as the Encana Corporation and the Cutbank Ridge Partnership a partnership between Encana and a partner of Mitsubishi Corporation, have accomplished the formerly declared sale of certain natural gas gathering and compression assets supporting development in the Montney area of northeastern British Columbia to Veresen Midstream Limited Partnership (“Veresen Midstream”), a 50/50 limited partnership of Veresen Inc. and associates of Kohlberg Kravis Roberts & Co. L.P. (“KKR”). Total cash consideration to Encana is about C$461 million.
Encana Corporation, together with its auxiliaries, engages in the development, exploration, production, and marketing of natural gas, oil, and natural gas liquids in Canada and the United States.
MEI Pharma Inc (NASDAQ:MEIP), gained 3.31%, and closed at $1.87, as the corporation declared that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present at the 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 1:40 p.m. Eastern time from the Westin Grand Central Hotel in New York.
A live webcast of the presentation can be accessed at www.meipharma.com. A replay will be accessible about one hour after the presentation.
MEI Pharma, Inc., an oncology corporation, focuses on the clinical development of novel therapies for the treatment of cancer. The corporations lead drug candidate is Pracinostat, an orally accessible histone deacetylase inhibitor, which is in Phase II clinical trial for the treatment of hematologic diseases, such as myelodysplastic syndrome and acute myeloid leukemia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
